Literature DB >> 8163793

Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts. AAAI Board of Directors. American Academy of Allergy and Immunology.

.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8163793     DOI: 10.1016/0091-6749(94)90265-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  6 in total

Review 1.  Allergic emergencies in the physician's office.

Authors:  P A Greenberger
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Minimising the risks of allergen-specific injection immunotherapy.

Authors:  H J Malling
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

3.  The safety of self-administered allergen immunotherapy during the buildup and maintenance phases.

Authors:  Frederick M Schaffer; Andrew R Naples; Myla Ebeling; Thomas C Hulsey; Larry M Garner
Journal:  Int Forum Allergy Rhinol       Date:  2014-12-04       Impact factor: 3.858

4.  Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI).

Authors:  Eric Leith; Tom Bowen; Joe Butchey; David Fischer; Harold Kim; Bill Moote; Peter Small; Don Stark; Susan Waserman
Journal:  Allergy Asthma Clin Immunol       Date:  2006-06-15       Impact factor: 3.406

Review 5.  Diagnosis and management of rhinitis.

Authors:  D Weldon
Journal:  Prim Care       Date:  1998-12       Impact factor: 2.907

6.  Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization.

Authors:  Stephen F Kemp; Richard F Lockey; F Estelle R Simons
Journal:  World Allergy Organ J       Date:  2008-07       Impact factor: 4.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.